Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1/2 5Phase 3 4Phase 2/3 1

Status

Recruiting 4

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 2Thoracic 1

Conditions

Nasopharyngeal Carcinoma 2Locally Advanced or Metastatic GC and GCJ Adenocarcinoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 81Carboplatin 76Magnetic Resonance Spectroscopy 73Specimen Handling 69Cisplatin 62Paclitaxel 55Gemcitabine 46Fluorouracil 37Dexamethasone 37Radiation 36Docetaxel 36Cyclophosphamide 36Radiotherapy 35Pemetrexed 35Doxorubicin 35Oxaliplatin 33Leucovorin 33Bevacizumab 31Capecitabine 28Vincristine 27durvalumab 26Etoposide 24Rituximab 23Taxes 22Irinotecan 22Nivolumab 21Letrozole 21Prednisone 20Biopsy 20Platinum 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × toripalimab × 30 days × Clear all
NCT06277050 2026-05-15

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Jiangxi Provincial Cancer Hospital

Phase 3 Recruiting
264 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT06437977 2026-05-13

neoR-TORCH

Shanghai Chest Hospital

Phase 3 Recruiting
478 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05340491 2026-05-11

Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial

Sun Yat-sen University

Phase 3 Recruiting
212 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT07362186 2026-05-11

LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

LaNova Medicines Limited

Phase 3 Recruiting
400 enrolled

Locally Advanced or Metastatic GC and GCJ Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡